Kimberly J. Payne

Kimberly J. Payne

Auto-generated profile, based on publicly available information

Kimberly J. Payne

Department of Pathology and Human Anatomy, Loma Linda University, Loma Linda, CA 92350, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2001 in Blood
Verified
Journal Article
Closed access
PDF file
QHQian-Lin Hao
Qian-Lin Hao
JZJudy Zhu
Judy Zhu
MPMary A. Price
Mary A. Price
KPKimberly J. Payne
Kimberly J. Payne
LBLora W. Barsky
Lora W. Barsky
GCGay M. Crooks
Gay M. Crooks
The earliest stages of lymphoid commitment from human pluripotent hematopoietic stem cells have not been defined. A clonogenic subpopulation of CD34+CD38− cord blood cells were identified that expressed high levels of the CD7 antigen and possessed only lymphoid potential. CD34+CD38−CD7+ (CD7+) cells uniformly coexpressed CD45RA and HLA-DR;c-kit and Thy-1 expression was absent to low. Clonal analysis demonstrated that single CD7+ cells could generate B cells, natural killer cells, and dendritic cells but were devoid of myeloid or erythroid potential. In contrast, control CD34+CD38−CD7−(CD7−) cells generated both lymphoid and myelo-erythroid cells. The lymphoid potential (generation of lymphoid progeny in bulk and single cell cultures) of CD7+ cells was equivalent to that of the pluripotent CD7− cells. RNA expression studies showed that CD7+ cells expressed PU.1 and GATA-3, but did not express Pax-5, terminal deoxynucleotide transferase, or CD3ε. In contrast to the previously described murine common lymphoid progenitor, the α chain of the receptor for interleukin-7 was not detected by fluorescence-activated cell sorting analysis or RNA polymerase chain reaction in CD7+cells. These studies identify a clonogenic lymphoid progenitor with both B-cell and natural killer cell lineage potential with a molecular profile that suggests a developmental stage more primitive than previously identified lymphoid progenitors. The CD7+phenotype distinguishes primitive human lymphoid progenitors from pluripotent stem cells, thus allowing the study of regulation of early human lymphopoiesis and providing an alternative to pluripotent stem cells for genetic manipulation and transplantation.

1 August 2001 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
KMKay L. Medina
Kay L. Medina
KGKarla P. Garrett
Karla P. Garrett
LTLinda F. Thompson
Linda F. Thompson
MRMaria Isabel D. Rossi
Maria Isabel D. Rossi
KPKimberly J. Payne
Kimberly J. Payne
PKPaul W. Kincade
Paul W. Kincade

15 June 2014 in Journal of Virology
Verified
Journal Article
Open access
PDF file
VWVonetta M. Williams
Vonetta M. Williams
MFMaria Filippova
Maria Filippova
VFValery Filippov
Valery Filippov
KPKimberly J. Payne
Kimberly J. Payne
Penelope Duerksen-HughesPenelope Duerksen-Hughes
Penelope Duerksen-Hughes
High-risk types of human papillomavirus (HPV) are the causative agents of virtually all cases of cervical cancer and a significant proportion of other anogenital cancers, as well as both oral and pharyngeal cancers. The high-risk types encode two viral oncogenes, E6 and E7, which work together to initiate cell transformation. Multiple steps involving the activities and interactions of both viral and cellular proteins are involved in the progression from HPV infection to cell transformation to cancer. The E6 oncoprotein is expressed as several isoforms: a full-length variant referred to as E6 and a few shorter isoforms collectively referred to as E6*. In this study, we found that expression of E6* increased the level of reactive oxygen species (ROS) in both HPV-positive and HPV-negative cells. This increased oxidative stress led to higher levels of DNA damage, as assessed by the comet assay, quantification of 8-oxoguanine, and poly(ADP-ribose) polymerase 1. The observed increase in ROS may be due to a decrease in cellular antioxidant activity, as we found that E6* expression also led to decreased expression of superoxide dismutase isoform 2 and glutathione peroxidase. These studies indicate that E6* may play an important role in virus-induced mutagenesis by increasing oxidative stress and DNA damage. IMPORTANCE Our findings demonstrate for the first time that an HPV gene product, E6*, can increase ROS levels in host cells. This ability may play a significant role both in the viral life cycle and in cancer development, because an increase in oxidative DNA damage may both facilitate HPV genome amplification and increase the probability of HPV16 DNA integration. Integration, in turn, is thought to be an important step in HPV-mediated carcinogenesis.

2 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DNDequina Angelina Nicholas
Dequina Angelina Nicholas
Kangling ZhangKangling Zhang
Kangling Zhang
CHChristopher Hung
Christopher Hung
SGShane Glasgow
Shane Glasgow
AAAruni Wilson Aruni
Aruni Wilson Aruni
MLMarino De Leon
Marino De Leon
Palmitic acid (PA) and other saturated fatty acids are known to stimulate pro-inflammatory responses in human immune cells via Toll-like receptor 4 (TLR4). However, the molecular mechanism responsible for fatty acid stimulation of TLR4 remains unknown. Here, we demonstrate that PA functions as a ligand for TLR4 on human monocyte derived dendritic cells (MoDCs). Hydrophobicity protein modeling indicated PA can associate with the hydrophobic binding pocket of TLR4 adaptor protein MD-2. Isothermal titration calorimetry quantified heat absorption that occurred during PA titration into TLR4/MD2, indicating that PA binds to TLR4/MD2. Treatment of human MoDCs with PA resulted in endocytosis of TLR4, further supporting the function of PA as a TLR4 agonist. In addition, PA stimulated DC maturation and activation based on the upregulation of DC costimulatory factors CD86 and CD83. Further experiments showed that PA induced TLR4 dependent secretion of the pro-inflammatory cytokine IL-1β. Lastly, our experimental data show that PA stimulation of NF-κB canonical pathway activation is regulated by TLR4 signaling and that reactive oxygen species may be important in upregulating this pro-inflammatory response. Our experiments demonstrate for the first time that PA activation of TLR4 occurs in response to direct molecular interactions between PA and MD-2. In summary, our findings suggest a likely molecular mechanism for PA induction of pro-inflammatory immune responses in human dendritic cells expressing TLR4.

1 January 2011 in Brain Research
Verified
Journal Article
Closed access
APAmelia Padilla
Amelia Padilla
MDMagda Descorbeth
Magda Descorbeth
AAAudra L. Almeyda
Audra L. Almeyda
KPKimberly Payne
Kimberly Payne
MLMarino De Leon
Marino De Leon

1 March 2000 in Immunity
Verified
Journal Article
Closed access
KTKim-Sue R.S Tudor
Kim-Sue R.S Tudor
KPKimberly J Payne
Kimberly J Payne
YYYoshio Yamashita
Yoshio Yamashita
PKPaul W Kincade
Paul W Kincade